Houston Chronicle Sunday

Scientists aim to learn role of age as COVID-19 risk factor

- By Amina Khan

They’re the cases that stand out because they don’t seem to fit the coronaviru­s pattern: A 32-year-old nurse died of COVID-19 after spending several days on a ventilator at Harbor-UCLA Medical Center. A 25-year-old pharmacy technician who had seemed to be in good health had succumbed to COVID-19 in a Riverside County home.

It’s enough to make you wonder: Is the coronaviru­s more dangerous to younger people than scientists initially thought?

When the outbreak took off in Wuhan, China, there was a distinct trend: the older the patient, the greater the risk of death. And as the virus spread around the world, that trend seemed to hold up. A study published in the medical journal Lancet that analyzed more than 70,000 cases from January and February found that the fatality rate for COVID-19 patients in their 30s was 0.15 percent, compared with 13.4 percent for those 80 and older.

But in the U.S., doctors on the front lines have noted strange and often alarming conditions in younger victims, including patients in their 30s and 40s dying of strokes after experienci­ng only mild COVID-19 symptoms. Children and teens have ended up in hospital intensive care units with symptoms of a rare inflammato­ry syndrome called Kawasaki disease that could be related to COVID-19, according to a bulletin released by the New York City Health Department last week.

For now, cases like these remain disparate pieces of a much larger puzzle. As scientists dig deeper, they hope to learn more about the role of age as a COVID-19 risk factor and why the disease is so dangerous to the elderly.

But in the meantime, they’re seeing that younger victims are still more the exception than the rule, even in the U.S. Here’s a closer look at what they know so far, and what they’re still trying to find out.

A one-sided pattern

Scientists generally agree that when it comes to age, the coronaviru­s doesn’t appear to discrimina­te, though pinning down the infection rate will require far more widespread testing than has been done so far.

“Anyone at any age can become infected,” said Dr. Timothy Brewer, an infectious disease specialist and epidemiolo­gist at the University of California, Los Angeles. “But we are seeing very different outcomes in what happens after people are infected.”

As the pandemic has grown, the risk of ending up in the hospital or dying has remained markedly higher for those in older age groups — a trend that’s become even more clear over time.

Soon after the Centers for Disease Control and Prevention began monitoring the coronaviru­s’ activity in the U.S., it found that for the week ending March 21, the COVID-19 hospitaliz­ation rate for those 65 and older was 10.4 per 100,000 people, compared with 1.9 per 100,000 people ages 18 to 49. By May 2, both figures had risen considerab­ly — to 162.2 hospitaliz­ations per 100,000 senior citizens and 26.2 per 100,000 younger adults — but the large gap remained.

In many infectious disease outbreaks, such as seasonal influenza, the very young and the very old face the greatest risk of serious illness and death. Researcher­s are still puzzled as to why COVID-19’s pattern is so one-sided, with infected children typically having only mild symptoms of the disease.

One potential explanatio­n is that the immune systems of children are too immature to trigger the massive inflammato­ry response that can lead to septic shock, organ failure and other complicati­ons in some COVID-19 patients, experts say.

Another hypothesis is that there are so many other types of mild coronaviru­ses circulatin­g among children that they have some kind of partial immunity against the SARS-CoV-2 coronaviru­s, the one that causes COVID-19.

Toll varies

The progressio­n of the outbreak and the toll it takes has varied from country to country, said Jennifer Beam Dowd, a demographe­r and social epidemiolo­gist at Oxford University. That’s because of a wide variety of factors, from the intensity of testing to the timing of lockdown orders and the way the disease first entered a country.

One key factor is the age structure of the population — how many people are old, how many are young and how many fill the categories in between.

Take Italy, a country of just more than 60 million people that has suffered close to 30,000 deaths so far (compared with just over 4,600 deaths in China, home to 1.4 billion people).

The odds may have been stacked against Italy because its population skews older: An estimated 23 percent of its citizens are 65 or older, according to U.N. world population data. In China, by contrast, just 12 percent of citizens are seniors. (In the U.S., it’s almost 17 percent.) With COVID-19, assuming that all ages get infected at a similar rate, an older population is likely to mean more deaths, and that seems to have held up in Italy, where more than 95 percent of deaths were in patients 60 and up, according to data from Italy’s COVID-19 surveillan­ce group.

In a study published in the Proceeding­s of the National Academy of Sciences, Dowd and her colleagues used models to explore how countries with similarly sized population­s but different age structures would fare in a coronaviru­s outbreak. Assuming a constant infection rate and using the age-specific death rates seen in Italy, they predicted that Brazil, where 2 percent of the population is at least 80, would have three times as many deaths as Nigeria, where only 0.2 percent of the population is over 80. (Brazil has about 210 million residents, only slightly more than Nigeria’s 196 million.)

The interactio­ns between people in different age groups may also play a role in who lives and who dies, Dowd said. For example, in Italy, older adults are more likely to live with their adult children than in other countries — and even if they don’t, they often live close enough to share meals on a regular basis, Dowd’s Italian colleagues told her.

There appear to be fewer such points of intergener­ational contact in Germany, and the death toll there has been significan­tly lower: around 7,400 fatalities so far out of more than 169,000 cases. (This despite Germany’s population being about one-third larger than Italy’s.)

“We do think that could be one of the important difference­s,” Dowd said.

In many countries, the coronaviru­s seems to have circulated undetected among younger people before making the jump to older people and causing enough serious illnesses and deaths to gain notice. That’s a problem, because it may be giving the virus a chance to quietly solidify its beachhead. But if an outbreak can be identified while it’s still contained in that younger, less vulnerable population, a separation between generation­s could serve as a protective buffer.

On a very basic level, age is essentiall­y a decline in the body’s ability to regenerate, said Brewer of UCLA.

“We can no longer repair ourselves and our cells at a rate that we can when we’re younger,” he said. “Not only does that affect things like our bones and our hearts, it affects our immune system as well.”

It could be that older people’s bodies are simply less capable of handling the virus. But that declining function often comes with a host of common chronic conditions, such as cardiovasc­ular disease, diabetes and hypertensi­on, and these could put a COVID-19 patient at greater risk of serious illness or death, regardless of their age, said Dr. Kirsten Bibbins-Domingo, chair of epidemiolo­gy and biostatist­ics at the University of California, San Francisco.

“It’s hard to disentangl­e the two,” she said. “You don’t know whether it’s the heart disease — or it’s being old.”

‘Accelerate­d aging’

For instance, people under 60 make up a larger share of COVID-19 deaths in the U.S. than they do in Europe, Bibbins-Domingo pointed out, and “it may be that we have more people who have heart disease at younger ages than they do in these other places.”

Separating these factors is an important step in tackling the disease, scientists said. That’s because many of those chronic health conditions are more prevalent in minority and underprivi­leged communitie­s.

If a region’s hospitaliz­ed COVID-19 patients skew slightly younger than expected, it might be a sign to look for these health disparitie­s, Dowd said.

“That probably is an interestin­g part of the story here,” she said.

A Los Angeles Times analysis found that younger black and Latino California­ns are dying of COVID-19 at higher rates than their white and Asian peers. That pattern is repeating itself across state boundaries, public health data show.

“We often talk about it as accelerate­d aging,” Dowd said. Deeply disadvanta­ged people in their 40s might have the same biological profile as more privileged people in their 60s, for example, “so that’s kind of an interestin­g lens with which to think about this.”

In that way, COVID-19 is bringing the country’s racial and socioecono­mic health disparitie­s into sharp focus, scientists said.

So does the coronaviru­s’ particular toll on older patients muddy these issues — or help clarify them?

“The answer is both,” Brewer said.

 ?? John Moore / Getty Images ?? A child gets a COVID-19 swab test in Stamford, Conn. Alarming conditions in younger COVID-19 victims are disparate pieces of a much larger puzzle about the role of age in getting the disease.
John Moore / Getty Images A child gets a COVID-19 swab test in Stamford, Conn. Alarming conditions in younger COVID-19 victims are disparate pieces of a much larger puzzle about the role of age in getting the disease.

Newspapers in English

Newspapers from United States